U.S. Commercial Metals, M&T Bank, Simon Property
Sept 3 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Commercial Metals, M&T Bank Corp and Simon Property Group, on Tuesday.
HIGHLIGHTS
* Autodesk Inc ADSK.O: Citigroup raises target price to $325 from $316 |
* Builders Firstsource BLDR.N: Oppenheimer raises target price to $205 from $190 |
* Commercial Metals Co CMC.N: Jefferies initiates with buy rating; price target $65 |
* M&T Bank Corp MTB.N: JP Morgan raises to overweight from neutral |
* Simon Property Group Inc SPG.N: Piper Sandler cuts to neutral from overweight |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* 10X Genomics TXG.O: Leerink Partners initiates coverage with outperform rating; PT $35 |
* Abercrombie & Fitch Co ANF.N: Jefferies raises target price to $220 from $215 |
* Adapthealth Corp AHCO.O: Jefferies raises target price to $10.50 from $9.50 |
* Aflac Inc AFL.N: Jefferies raises target price to $97 from $88 |
* Allegro Microsystems Inc ALGM.O: UBS initiates coverage with buy rating and PT $33 |
* Allstate Corp ALL.N: TD Cowen raises target price to $224 from $193 |
* Ally Financial Inc ALLY.N: Goldman Sachs removes stock from its US conviction list |
* Alphabet Inc GOOGL.O: Morgan Stanley cuts target price to $190 from $205 |
* American Healthcare REIT AHR.N: Truist Securities raises PT to $22 from $17 |
* Ameriprise Financial Inc AMP.N: Jefferies raises target price to $511 from $506 |
* Applied Optoelectronics AAOI.O: Raymond James raises to outperform from market perform |
* Arrowhead Pharmaceuticals ARWR.O: Leerink Partners raises PT to $20 from $19 |
* Autodesk Inc ADSK.O: Citigroup raises target price to $325 from $316 |
* Axsome Therapeutics AXSM.O: Wells Fargo initiates coverage with overweight rating and PT $140 |
* Boeing BA.N: Wells Fargo cuts target price to $119 from $185 |
* Boeing BA.N: Wells Fargo cuts to underweight from equal weight |
* Brown-Forman Corp BFb.N: Roth MKM cuts target price to $48 from $49 |
* Builders Firstsource BLDR.N: Oppenheimer raises target price to $205 from $190 |
* Burlington Stores Inc BURL.N: UBS raises target price to $270 from $238 |
* BXP Inc BXP.N: Piper Sandler raises target price to $78 from $70 |
* Ciena Corp CIEN.N: JP Morgan raises target price to $65 from $60 |
* Ciena Corp CIEN.N: Stifel raises target price to $68 from $62 |
* Cinemark Holdings Inc CNK.N: Wedbush raises target price to $31 from $28 |
* Clean Energy Fuels Corp CLNE.O: Scotiabank raises target price to $6 from $5 |
* CME Group Inc CME.O: BofA Global Research cuts price objective to $177 from $212 |
* CME Group Inc CME.O: BofA Global Research cuts to underperform from neutral |
* CNO Financial Group Inc CNO.N: Jefferies raises target price to $31 from $29 |
* Cogent Biosciences Inc COGT.O: Wedbush raises target price to $11 from $10 |
* Commercial Metals Co CMC.N: Jefferies initiates with buy rating; price target $65 |
* Conagra Brands Inc CAG.N: Goldman Sachs adds stock to its US conviction list |
* Core & Main Inc CNM.N: JP Morgan cuts target price to $52 from $54 |
* Corebridge Financial Inc CRBG.N: Jefferies raises target price to $39 from $37 |
* Crowdstrike CRWD.O: Deutsche Bank raises target price to $285 from $275 |
* Dave & Buster'S Entertainment Inc PLAY.O: UBS cuts target price to $35 from $56 |
* Deckers Brands DECK.N: Wedbush removes stock from its best ideas list |
* Delek US Holdings Inc DK.N: Wells Fargo raises target price to $21 from $20 |
* Dick's Sporting Goods Inc DKS.N: TD Cowen raises target price to $270 from $266 |
* Dollar General Corp DG.N: Goldman Sachs removes stock from its US conviction list |
* Dollar General Corporation DG.N: Barclays cuts target price to $102 from $154 |
* Envoy Medical Inc COCH.O: Ascendiant Capital Markets raises PT to $8.75 from $8.50 |
* Eve Holding Inc EVEX.N: H.C. Wainwright initiates coverage with buy rating; PT $6 |
* Factset FDS.N: Deutsche Bank cuts target price to $454 from $461 |
* Foghorn Therapeutics FHTX.O: Jefferies initiates coverage with buy rating; PT $18 |
* Forge Global Holdings Inc FRGE.N: UBS raises to buy from neutral - |
* Glaukos Corp GKOS.N: Stifel raises target price to $145 from $130 |
* Globe Life Inc GL.N: Jefferies raises target price to $95 from $90 |
* Green Plains Inc GPRE.O: Jefferies cuts target price to $28 from $37 |
* Hannon Armstrong HASI.N: RBC initiates coverage with outperform rating |
* Hannon Armstrong HASI.N: RBC initiates coverage with PT $41 |
* HCA Healthcare HCA.N: Deutsche Bank raises target price to $441 from $375 |
* HCA Healthcare HCA.N: Jefferies raises target price to $455 from $390 |
* HF Sinclair Corporation DINO.N: Wells Fargo cuts target price to $54 from $60 |
* IBM IBM.N: Goldman Sachs adds stock to its US conviction list |
* Inari Medical NARI.O: Leerink Partners initiates coverage with market perform rating; PT $47 |
* Insmed Inc INSM.O: Goldman Sachs adds stock to its US conviction list |
* Installed Building Products IBP.N: Goldman Sachs removes stock from its US conviction list |
* International Flavors & Fragrances IFF.N: Mizuho raises PT to $120 from $109 |
* International Flavors & Fragrances IFF.N: Mizuho raises to outperform from neutral |
* Jabil Inc JBL.N: JP Morgan cuts target price to $133 from $137 |
* Jackson Financial Inc JXN.N: Jefferies raises target price to $78 from $74 |
* Joby Aviation Inc JOBY.N: H.C. Wainwright initiates coverage with buy rating; PT $9 |
* Kite Realty Group Trust KRG.N: Piper Sandler raises target price to $33 from $30 |
* Lifeway Foods Inc LWAY.O: Noble Capital raises target price to $25 from $20 |
* Lincoln National Corp LNC.N: Jefferies raises target price to $40 from $38 |
* M&T Bank Corp MTB.N: JP Morgan raises target price to $215 from $183 |
* M&T Bank Corp MTB.N: JP Morgan raises to overweight from neutral |
* Macerich Co MAC.N: Piper Sandler raises target price to $14 from $11 |
* Medical Properties Trust Inc MPW.N: RBC cuts target price to $4 from $5 |
* Metlife Inc MET.N: Jefferies raises target price to $89 from $81 |
* Mongodb Inc MDB.O: Citigroup raises target price to $400 from $350 |
* Montauk Renewables MNTK.O: Scotiabank cuts target price to $6 from $8 |
* Montauk Renewables MNTK.O: Scotiabank cuts to sector perform from sector outperform |
* Motorola MSI.N: Jefferies raises target price to $510 from $460 |
* National Health Investors Inc NHI.N: Truist Securities raises PT to $78 from $65 |
* nCino Inc NCNO.O: Raymond James raises to outperform from market perform |
* Newmark Group Inc NMRK.O: Piper Sandler raises target price to $17 from $13 |
* Nextera Energy Inc NEE.N: Wells Fargo raises target price to $102 from $95 |
* Nucana Plc NCNA.O: Oppenheimer cuts target price to $25 from $150 |
* Okta OKTA.O: Deutsche Bank cuts target price to $115 from $125 |
* Olin Corp OLN.N: BMO initiates coverage with market perform rating; target price $50 |
* ONEOK Inc OKE.N: Citigroup raises target price to $102 from $85 |
* Opal Fuels Inc OPAL.O: Scotiabank cuts target price to $5 from $8 |
* Opal Fuels Inc OPAL.O: Scotiabank cuts to sector perform from sector outperform |
* PBF Energy Inc PBF.N: Wells Fargo cuts target price to $51 from $52 |
* Penumbra PEN.N: Leerink Partners initiates coverage with outperform rating; PT $263 |
* Procept Biorobotics Corp PRCT.O: Truist Securities raises PT to $95 from $74 |
* Progressive Corp PGR.N: BofA Global Research raises price objective to $312 from $294 |
* Progressive Corp PGR.N: KBW raises target price to $275 from $255 |
* Prudential Financial Inc PRU.N: Jefferies raises target price to $140 from $132 |
* Recursion Pharmaceuticals Inc RXRX.O: Leerink Partners cuts PT to $8 from $9 |
* Reinsurance Group of America Inc RGA.N: Jefferies raises PT to $268 from $253 |
* Royal Caribbean Group RCL.N: Goldman Sachs removes stock from its US conviction list |
* Sable Offshore Corp SOC.N: TD Cowen raises target price to $26 from $20 |
* Simon Property Group Inc SPG.N: Piper Sandler cuts target price to $175 from $190 |
* Simon Property Group Inc SPG.N: Piper Sandler cuts to neutral from overweight |
* Soho House & Co SHCO.N: Morgan Stanley resumes with equal-weight rating; PT $5.50 |
* Soleno Therapeutics SLNO.O: H.C. Wainwright initiates coverage with buy rating and PT $70 |
* Sotherly Hotels Inc SOHO.O: Piper Sandler cuts target price to $1.50 from $2 |
* Southwest Airlines Co LUV.N: Evercore ISI raises target price to $35 from $30 |
* Southwest Airlines Co LUV.N: Evercore ISI raises to outperform from in line |
* Sphere Entertainment Co SPHR.N: Benchmark cuts to sell |
* Sprinklr Inc CXM.N: Rosenblatt Securities cuts target price to $11 from $14 |
* Steel Dynamics Inc STLD.O: UBS raises target price to $145 from $129 |
* Steel Dynamics Inc STLD.O: UBS raises to buy from neutral |
* Tenable Holdings Inc TENB.O: Wedbush removes stock from its best ideas list |
* Unity Software Inc U.N: Morgan Stanley raises to overweight from equal-weight |
* Unum Group UNM.N: Jefferies raises target price to $67 from $6 |
* Valero Energy Corp. VLO.N: Wells Fargo raises target price to $172 from $165 |
* Vaxcyte Inc PCVX.O: Jefferies raises target price to $129 from $108 |
* Veeva Systems Inc VEEV.N: Truist Securities raises target price to $207 from $197 |
* Vera Therapeutics Inc VERA.O: JP Morgan raises target price to $72 from $62 |
* Walgreens WBA.O: Leerink Partners cuts target price to $9 from $11 |
* Westlake Corp WLK.N: BMO assumes coverage with market perform rating; PT $171 |
* Willdan Group WLDN.O: Wedbush assumes coverage with outperform rating; PT $51 vs $35 |
* Xylem Inc XYL.N: TD Cowen cuts to hold from buy |
(Compiled by Bengaluru Newsroom)
</body></html>Ähnliche Finanzinstrumente
Neueste News
Rechtlicher Hinweis: Die Unternehmen der XM Group bieten Dienstleistungen ausschließlich zur Ausführung an sowie Zugang zu unserer Online-Handelsplattform. Durch diese können Personen die verfügbaren Inhalte auf oder über die Internetseite betrachten und/oder nutzen. Eine Änderung oder Erweiterung dieser Regelung ist nicht vorgesehen und findet nicht statt. Der Zugang wird stets geregelt durch folgende Vorschriften: (i) Allgemeine Geschäftsbedingungen; (ii) Risikowarnungen und (iii) Vollständiger rechtlicher Hinweis. Die bereitgestellten Inhalte sind somit lediglich als allgemeine Informationen zu verstehen. Bitte beachten Sie, dass die Inhalte auf unserer Online-Handelsplattform keine Aufforderung und kein Angebot zum Abschluss von Transaktionen auf den Finanzmärkten darstellen. Der Handel auf Finanzmärkten birgt ein hohes Risiko für Ihr eingesetztes Kapital.
Sämtliche Materialien, die auf unserer Online-Handelsplattform veröffentlicht sind, dienen ausschließlich dem Zweck der Weiterbildung und Information. Die Materialien beinhalten keine Beratung und Empfehlung im Hinblick auf Finanzen, Anlagesteuer oder Handel und sollten nicht als eine dahingehende Beratung und Empfehlung aufgefasst werden. Zudem enthalten die Materialien keine Aufzeichnungen unserer Handelspreise sowie kein Angebot und keine Aufforderung für jegliche Transaktionen mit Finanzinstrumenten oder unverlangte Werbemaßnahmen für Sie zum Thema Finanzen. Die Materialien sollten auch nicht dahingehend aufgefasst werden.
Alle Inhalte von Dritten und die von XM bereitgestellten Inhalte sowie die auf dieser Internetseite zur Verfügung gestellten Meinungen, Nachrichten, Forschungsergebnisse, Analysen, Kurse, sonstigen Informationen oder Links zu Seiten von Dritten werden ohne Gewähr bereitgestellt. Sie sind als allgemeine Kommentare zum Marktgeschehen zu verstehen und stellen keine Anlageberatung dar. Soweit ein Inhalt als Anlageforschung aufgefasst wird, müssen Sie beachten und akzeptieren, dass der Inhalt nicht in Übereinstimmung mit gesetzlichen Bestimmungen zur Förderung der Unabhängigkeit der Anlageforschung erstellt wurde. Somit ist der Inhalt als Werbemitteilung unter Beachtung der geltenden Gesetze und Vorschriften anzusehen. Bitte stellen Sie sicher, dass Sie unseren Hinweis auf die nicht unabhängige Anlageforschung und die Risikowarnung im Hinblick auf die vorstehenden Informationen gelesen und zur Kenntnis genommen haben, die Sie hier finden.